{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T12:22:40Z","timestamp":1780921360815,"version":"3.54.1"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,8]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To assess the age-specific proportion of visual impairment in patients with pseudoxanthoma elasticum (PXE) and to compare this with foveal abnormality and similar data of late age-related macular degeneration patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Cross-sectional data of 195 patients with PXE were reviewed, including best-corrected visual acuity and imaging. The World Health Organisation criteria were used to categorize bilateral visual impairment. These results were compared with similar data of 131 patients with late age-related macular degeneration from the Rotterdam study.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Overall, 50 PXE patients (26.0%) were visually impaired, including 21 (11%) with legal blindness. Visual functioning declined with increasing age. In patients older than 50 years, 37% was visually impaired and 15% legally blind. Foveal choroidal neovascularization was found in 84% of eyes with a best-corrected visual acuity lower than 20\/70 (0.30) and macular atrophy in the fovea in 16%. In late age-related macular degeneration patients, 40% were visually impaired and 13% legally blind. Visual impairment started approximately 20 years later as compared with PXE patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Visual impairment and blindness are frequent in PXE, particularly in patients older than 50 years. Although choroidal neovascularization is associated with the majority of vision loss, macular atrophy is also common. The proportion of visual impairment in PXE is comparable with late age-related macular degeneration but manifests earlier in life.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000002173","type":"journal-article","created":{"date-parts":[[2018,4,13]],"date-time":"2018-04-13T16:28:41Z","timestamp":1523636921000},"page":"1580-1587","source":"Crossref","is-referenced-by-count":36,"title":["VISUAL ACUITY IN PSEUDOXANTHOMA ELASTICUM"],"prefix":"10.1097","volume":"39","author":[{"given":"Sara","family":"Risseeuw","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, University Medical Center Utrecht, the Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannette","family":"Ossewaarde-van Norel","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Medical Center Utrecht, the Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline C. W.","family":"Klaver","sequence":"additional","affiliation":[{"name":"Ophthalmology, and"},{"name":"Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands; and"},{"name":"Department of Ophthalmology, Radboud Medical Center, Nijmegen, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna M.","family":"Colijn","sequence":"additional","affiliation":[{"name":"Ophthalmology, and"},{"name":"Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia M.","family":"Imhof","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Medical Center Utrecht, the Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Redmer","family":"van Leeuwen","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Medical Center Utrecht, the Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230816","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/jid.2013.20","article-title":"Pseudoxanthoma elasticum: progress in research toward treatment: summary of the 2012 PXE international research meeting","volume":"133","author":"Uitto","year":"2013","journal-title":"J Invest Dermatol"},{"key":"R2-20230816","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/76102","article-title":"Mutations in a gene encoding an ABC transporter cause pseudoxanthoma elasticum","volume":"25","author":"Le Saux","year":"2000","journal-title":"Nat Genet"},{"key":"R3-20230816","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/76109","article-title":"Mutations in ABCC6 cause pseudoxanthoma elasticum","volume":"25","author":"Bergen","year":"2000","journal-title":"Nat Genet"},{"key":"R4-20230816","doi-asserted-by":"crossref","first-page":"6001","DOI":"10.1073\/pnas.100041297","article-title":"Pseudoxanthoma elasticum: mutations in the MRP6 gene encoding a transmembrane ATP-binding cassette (ABC) transporter","volume":"97","author":"Ringpfeil","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R5-20230816","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fgene.2013.00014","article-title":"An update on the ocular phenotype in patients with pseudoxanthoma elasticum","volume":"4","author":"Gliem","year":"2013","journal-title":"Front Genet"},{"key":"R6-20230816","first-page":"81","article-title":"Angioid streaks, clinical course, complications, and current therapeutic management","volume":"5","author":"Georgalas","year":"2009","journal-title":"Ther Clin Risk Manag"},{"key":"R7-20230816","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.survophthal.2008.12.006","article-title":"Pseudoxanthoma elasticum: genetics, clinical manifestations and therapeutic approaches","volume":"54","author":"Finger","year":"2009","journal-title":"Surv Ophthalmol"},{"key":"R8-20230816","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/IAE.0b013e31826b0bbe","article-title":"The time course changes of choroidal neovascularization in angioid streaks","volume":"33","author":"Nakagawa","year":"2013","journal-title":"Retina"},{"key":"R9-20230816","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ajo.2011.03.022","article-title":"Monthly ranibizumab for choroidal neovascularizations secondary to angioid streaks in pseudoxanthoma elasticum: a one-year prospective study","volume":"152","author":"Finger","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"R10-20230816","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1136\/bjo.2007.129916","article-title":"Intravitreal bevacizumab for choroidal neovascularisation associated with pseudoxanthoma elasticum","volume":"92","author":"Finger","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"R11-20230816","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1097\/IAE.0b013e3182914d2b","article-title":"Treatment of choroidal neovascularization due to angioid streaks. A comprehensive review","volume":"33","author":"Gliem","year":"2013","journal-title":"Retina"},{"key":"R12-20230816","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10633-007-9100-y","article-title":"Non-vascular vision loss in pseudoxanthoma elasticum","volume":"117","author":"Tsui","year":"2008","journal-title":"Doc Ophthalmol"},{"key":"R13-20230816","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1167\/iovs.16-19388","article-title":"Frequency, phenotypic characteristics and progression of atrophy associated with a diseased Bruch's membrane in pseudoxanthoma elasticum","volume":"57","author":"Gliem","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R14-20230816","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1097\/IAE.0b013e3181aade47","article-title":"Fundus autofluorescence in Pseudoxanthoma elasticum","volume":"29","author":"Finger","year":"2009","journal-title":"Retina"},{"key":"R15-20230816","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.ajo.2013.05.034","article-title":"Geographic chorioretinal atrophy in pseudoxanthoma elasticum","volume":"156","author":"Schoenberger","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"R16-20230816","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/1477-7525-9-113","article-title":"The relative impact of vision impairment and cardiovascular disease on quality of life: the example of pseudoxanthoma elasticum","volume":"9","author":"Finger","year":"2011","journal-title":"Health Qual Life Outcomes"},{"key":"R17-20230816","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/ajmg.a.33329","article-title":"Proposal for updating the pseudoxanthoma elasticum classification system and a review of the clinical findings","volume":"152","author":"Plomp","year":"2010","journal-title":"Am J Med Genet A"},{"key":"R20-20230816","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/BF00145007","article-title":"Determinants of disease and disability in the elderly: the Rotterdam elderly study","volume":"7","author":"Hofman","year":"1991","journal-title":"Eur J Epidemiol"},{"key":"R21-20230816","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s10654-017-0321-4","article-title":"The Rotterdam Study: 2018 update on objectives, design and main results","volume":"32","author":"Ikram","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"R22-20230816","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/S0161-6420(03)00501-3","article-title":"Grading of age-related maculopathy for epidemiological studies: is digital imaging as good as 35-mm film?","volume":"110","author":"Van Leeuwen","year":"2003","journal-title":"Ophthalmology"},{"key":"R23-20230816","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/bjophthalmol-2013-303235","article-title":"New insights into the visual prognosis of pseudoxanthoma elasticum","volume":"98","author":"Ebran","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"R24-20230816","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3109\/13816810.2014.886268","article-title":"Visual impairment in pseudoxanthoma elasticum: a survey of 40 patients","volume":"36","author":"Orssaud","year":"2015","journal-title":"Ophthalmic Genet"},{"key":"R25-20230816","doi-asserted-by":"crossref","first-page":"449","DOI":"10.5301\/ejo.5000766","article-title":"Visual impairment in pseudoxanthoma elasticum: a survey of 53 patients from Turkey","volume":"26","author":"Hocaoglu","year":"2016","journal-title":"Eur J Ophthalmol"},{"key":"R26-20230816","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.ophtha.2006.01.037","article-title":"Fundus autofluorescence in patients with pseudoxanthoma elasticum","volume":"113","author":"Sawa","year":"2006","journal-title":"Ophthalmology"},{"key":"R27-20230816","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1167\/iovs.05-1604","article-title":"Pseudoxanthoma elasticum with generalized retinal dysfunction, a common finding?","volume":"48","author":"Audo","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R28-20230816","doi-asserted-by":"crossref","first-page":"387","DOI":"10.4103\/0974-9233.71586","article-title":"Intravitreal avastin for choroidal neovascularization associated with stargardt-like retinal abnormalities in pseudoxanthoma elasticum","volume":"17","author":"Querques","year":"2010","journal-title":"Middle East Afr J Ophthalmol"},{"key":"R29-20230816","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.exer.2004.09.006","article-title":"Impaired RPE survival on aged submacular human Bruch's membrane","volume":"80","author":"Gullapalli","year":"2005","journal-title":"Exp Eye Res"},{"key":"R30-20230816","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1001\/jamaophthalmol.2013.5799","article-title":"Geographic atrophy: a histopathological assessment","volume":"132","author":"Bird","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"R31-20230816","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1161\/ATVBAHA.114.304017","article-title":"ABCC6-mediated ATP secretion by the liver is the main source of the mineralization inhibitor inorganic pyrophosphate in the systemic circulation-brief report","volume":"34","author":"Jansen","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R32-20230816","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"N Engl J Med"},{"key":"R33-20230816","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1097\/IAE.0b013e318207d1dc","article-title":"Long-term effectiveness of intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks in pseudoxanthoma elasticum","volume":"31","author":"Finger","year":"2011","journal-title":"Retina"},{"key":"R34-20230816","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1600-0420.2006.00762.x","article-title":"Choroidal neovascularization treated with intravitreal injection of bevacizumab (Avastin) in angioid streaks","volume":"84","author":"Teixeira","year":"2006","journal-title":"Acta Ophthalmol Scand"},{"key":"R35-20230816","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/IAE.0b013e3181c596b1","article-title":"Long-term outcomes of intravitreal antivascular endothelial growth factor therapy for the management of choroidal neovascularization in pseudoxanthoma elasticum","volume":"30","author":"Myung","year":"2010","journal-title":"Retina"},{"key":"R36-20230816","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1097\/IAE.0000000000000081","article-title":"Exacerbation of choroidal and retinal pigment epithelial atrophy after anti-vascular endothelial growth factor treatment in neovascular age-related macular degeneration","volume":"34","author":"Young","year":"2014","journal-title":"Retina"},{"key":"R37-20230816","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ophtha.2013.08.015","article-title":"Risk of geographic atrophy in the comparison of age-related macular degeneration treatments trials","volume":"121","author":"Grunwald","year":"2014","journal-title":"Ophthalmology"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006982-201908000-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:30:02Z","timestamp":1692232202000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006982-201908000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000002173","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]}}}